Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer. Its lead immuno-oncology drug candidate, sotigalimab, is a potent immune-activating antibody against CD40 currently in Phase 2 clinical development.
View Top Employees from Apexigen| Website | http://www.apexigen.com |
| Revenue | $7 million |
| Funding | $223 million |
| Employees | 29 (29 on RocketReach) |
| Founded | 2010 |
| Address | 75 Shoreway Road Suite C, San Carlos, California 94070, US |
| Phone | (650) 931-6236 |
| Fax | (650) 931-6235 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+12 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Biopharma, Drug Discovery, Business Services, Health Care, Science and Engineering |
| Web Rank | 9 Million |
| Keywords | Apexigen, Apexigen Aacr Poster, Apexigen Stock |
| Competitors | Affimed, Alethia Biotherapeutics Inc., Cancer Prevention Pharmaceuticals, Inc, Compass Therapeutics Inc., Trellis Bioscience |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular Apexigen employee's phone or email?
Apexigen Questions
The Apexigen annual revenue was $7 million in 2024.
Francis Willard Sarena is the President and Chief Operating Officer of Apexigen.
29 people are employed at Apexigen.
Apexigen is based in San Carlos, California.
The NAICS codes for Apexigen are [541, 54, 54171, 5417, 541714].
The SIC codes for Apexigen are [873, 87].
Top Apexigen Employees
-
View
Francis Willard Sarena
President and Chief Operating Officer at Apexigen
California, United States45+ -
55+
-
14
-
5+4
-
25+
-
41
Related Companies
